E1	Age:T1 Numeric-Filter:E2
E2	Eq-Comparison:T2 Value:T68 Temporal-Unit:T69 Operator:T70
E3	Eq-Comparison:T3 Temporal-Period:T71
E7	Modifier:T7 Modifies:T75
E9	Procedure:T9 Name:T75 Temporality:E3
E10	Assertion:T10 Asserted:E11
E11	Procedure:T11 Name:T76 Duration:E12
E12	Eq-Comparison:T12 Value:T77 Temporal-Unit:T78 Operator:T79
E13	Risk:T13 Polarity:T80 Risk-For:E14
E14	Condition:T14 Name:T81
E15	Observation:T15 Name:T82
E16	Eq-Comparison:T16 Value:T84 Operator:T74
E17	Observation:T17 Name:T85
E18	Observation:T18 Name:T86 Numeric-Filter:E19
E19	Eq-Comparison:T19 Unit:T87 Operator:T88 Value:T89
E21	Observation:T21 Name:T133 Numeric-Filter:E22
E22	Eq-Comparison:T22 Operator:T90 Value:T91 Temporal-Unit:T92
E24	Eq-Comparison:T24 Temporal-Period:T93
E25	Condition:T25 Name:T94 Temporality:E24
E27	Condition:T27 Name:T95
E28	Eq-Comparison:T28 Temporal-Period:T96
E29	Condition:T29 Name:T97 Temporality:E28
E30	Condition:T30 Name:T99 Severity:T98
E31	Observation:T31 Name:T100 Numeric-Filter:E32
E32	Eq-Comparison:T32 Operator:T101 Value:T102
E34	Condition:T34 Name:T136 Temporality:E35
E35	Eq-Comparison:T35 Operator:T103 Value:T104 Temporal-Unit:T105
E36	Drug:T36 Name:T106
E37	Drug:T37 Name:T107
E39	Drug:T39 Name:T108 Temporality:E40
E40	Eq-Comparison:T40 Operator:T109 Value:T110 Temporal-Unit:T111
E42	Procedure:T42 Name:T112
E43	Condition:T43 Name:T114 Severity:T113
E44	Assertion:T44 Asserted:E45
E45	Procedure:T45 Name:T115
E47	Condition:T47 Name:T117 Severity:T116
E48	Observation:T48 Name:T118 Numeric-Filter:E49
E49	Eq-Comparison:T49 Unit:T119 Value:T120
E50	Eq-Comparison:T50 Temporal-Period:T121
E51	Condition:T51 Name:T123 Acuteness:T122 Temporality:E50 Temporality2:E52
E52	Eq-Comparison:T52 Operator:T124 Value:T125 Temporal-Unit:T126
E54	Procedure:T54 Name:T127
E55	Assertion:T55 Asserted:E56
E56	Study:T56 
E57	Procedure:T57 Name:T128
E58	Other:T58 Is-Other:E59
E59	Study:T59 
E61	Eq-Comparison:T61 Temporal-Period:T129 Temporal-Unit:T130
E63	Eq-Comparison:T63 Value:T131 Unit:T132
E65	Study:T65 Study-Of:E66
E66	Drug:T66 
E67	Study:T67 Temporality:E74
E4	Modifier:T4 Modifies:T75
E6	Modifier:T6 Modifies:T75
E68	Modifier:T72 Modifies:T75
E69	Observation:T73 Name:T83 Numeric-Filter:E16
E70	Procedure:T134 Name:T135
E71	Assertion:T137 Asserted:E72
E72	Negation:T138 Negates:E57
E74	Eq-Comparison:T140 Temporal-Recency:T141
T1	Age 25 28	Age
T2	Eq-Comparison 32 48	50 years or over
T3	Eq-Comparison 55 75	Scheduled to undergo
T7	Modifier 105 120	upper abdominal
T9	Procedure 138 145	surgery
T10	Assertion 156 164	expected
T11	Procedure 177 184	surgery
T12	Eq-Comparison 188 205	2 hours or longer
T13	Risk 231 235	risk
T14	Condition 239 243	PPCs
T15	Observation 261 279	ARISCAT risk score
T16	Eq-Comparison 306 309	≥45
T17	Observation 337 374	American Society of Anesthesiologists
T18	Observation 376 379	ASA
T19	Eq-Comparison 390 409	classification ≥ IV
T21	Observation 417 434	expected survival
T22	Eq-Comparison 444 450	≤ 24 h
T24	Eq-Comparison 470 477	history
T25	Condition 481 502	prostatic hypertrophy
T27	Condition 506 514	glaucoma
T28	Eq-Comparison 521 528	History
T29	Condition 532 553	myocardial infarction
T30	Condition 562 579	heart dysfunction
T31	Observation 581 618	New York Heart Association functional
T32	Eq-Comparison 619 637	classification ≥ 3
T34	Condition 642 657	tachyarrhythmia
T35	Eq-Comparison 658 673	within one year
T36	Drug 694 715	β2-receptor activator
T37	Drug 717 736	M-receptor blockers
T39	Drug 744 759	glucocorticoids
T40	Eq-Comparison 760 776	within one month
T42	Procedure 784 791	surgery
T43	Condition 805 822	renal dysfunction
T44	Assertion 824 835	requirement
T45	Procedure 839 864	renal replacement therapy
T47	Condition 876 895	hepatic dysfunction
T48	Observation 897 907	Child-Pugh
T49	Eq-Comparison 908 915	grade C
T50	Eq-Comparison 923 930	History
T51	Condition 940 946	stroke
T52	Eq-Comparison 947 966	within three months
T54	Procedure 974 981	surgery
T55	Assertion 988 997	Refuse to
T56	Study 1017 1022	study
T57	Procedure 1055 1073	inhalation therapy
T58	Other 1097 1102	other
T59	Study 1103 1117	clinical trial
T61	Eq-Comparison 1129 1139	last month
T63	Eq-Comparison 1143 1167	within the six half-life
T65	Study 1183 1188	study
T66	Drug 1189 1193	drug
T67	Study 1211 1216	trial
T68	Eq-Value 32 34	50
T69	Eq-Temporal-Unit 35 40	years
T70	Eq-Operator 41 48	or over
T71	Eq-Temporal-Period 55 75	Scheduled to undergo
T75	Procedure-Name 138 145	surgery
T76	Procedure-Name 177 184	surgery
T77	Eq-Value 188 189	2
T78	Eq-Temporal-Unit 190 195	hours
T79	Eq-Operator 196 205	or longer
T80	Polarity 226 230	high
T81	Condition-Name 239 243	PPCs
T82	Observation-Name 261 279	ARISCAT risk score
T83	Observation-Name 281 305	ARISCAT predictive score
T84	Eq-Value 307 309	45
T85	Observation-Name 337 374	American Society of Anesthesiologists
T86	Observation-Name 376 379	ASA
T87	Eq-Unit 390 404	classification
T88	Eq-Operator 405 406	≥
T89	Eq-Value 407 409	IV
T90	Eq-Operator 444 445	≤
T91	Eq-Value 446 448	24
T92	Eq-Temporal-Unit 449 450	h
T93	Eq-Temporal-Period 470 477	history
T94	Condition-Name 481 502	prostatic hypertrophy
T95	Condition-Name 506 514	glaucoma
T96	Eq-Temporal-Period 521 528	History
T97	Condition-Name 532 553	myocardial infarction
T98	Severity 555 561	severe
T99	Condition-Name 562 579	heart dysfunction
T100	Observation-Name 581 618	New York Heart Association functional
T101	Eq-Operator 634 635	≥
T102	Eq-Value 636 637	3
T103	Eq-Operator 658 664	within
T104	Eq-Value 665 668	one
T105	Eq-Temporal-Unit 669 673	year
T106	Drug-Name 694 715	β2-receptor activator
T107	Drug-Name 717 736	M-receptor blockers
T108	Drug-Name 744 759	glucocorticoids
T109	Eq-Operator 760 766	within
T110	Eq-Value 767 770	one
T111	Eq-Temporal-Unit 771 776	month
T112	Procedure-Name 784 791	surgery
T113	Severity 798 804	Severe
T114	Condition-Name 805 822	renal dysfunction
T115	Procedure-Name 839 864	renal replacement therapy
T116	Severity 869 875	severe
T117	Condition-Name 876 895	hepatic dysfunction
T118	Observation-Name 897 907	Child-Pugh
T119	Eq-Unit 908 913	grade
T120	Eq-Value 914 915	C
T121	Eq-Temporal-Period 923 930	History
T122	Acuteness 934 939	acute
T123	Condition-Name 940 946	stroke
T124	Eq-Operator 947 953	within
T125	Eq-Value 954 959	three
T126	Eq-Temporal-Unit 960 966	months
T127	Procedure-Name 974 981	surgery
T128	Procedure-Name 1055 1073	inhalation therapy
T129	Eq-Temporal-Period 1129 1133	last
T130	Eq-Temporal-Unit 1134 1139	month
T131	Eq-Value 1154 1157	six
T132	Eq-Unit 1158 1167	half-life
T4	Modifier 76 80	open
T6	Modifier 84 104	laparoscope assisted
T72	Modifier 124 137	intrathoracic
T73	Observation 281 305	ARISCAT predictive score
T74	Eq-Operator 306 307	≥
T133	Observation-Name 417 434	expected survival
T134	Procedure 460 469	operative
T135	Procedure-Name 460 469	operative
T136	Condition-Name 642 657	tachyarrhythmia
T137	Assertion 1026 1032	unable
T138	Negation 1026 1032	unable
T140	Eq-Comparison 1206 1210	last
T141	Eq-Temporal-Recency 1206 1210	last
A1	Assertion-Type-Value E10 hypothetical
A4	Assertion-Type-Value E44 hypothetical
A6	Assertion-Type-Value E55 hypothetical
A9	Eq-Temporal-Unit-Value T69 year
A10	Eq-Operator-Value T70 GTEQ
A11	Eq-Temporal-Period-Value T71 future
A13	Eq-Temporal-Unit-Value T78 hour
A14	Eq-Operator-Value T79 GTEQ
A15	Polarity-Value T80 high
A16	Observation-Type-Value E15 clinical-score
A17	Observation-Type-Value E69 clinical-score
A18	Eq-Operator-Value T88 GTEQ
A19	Eq-Operator-Value T90 LTEQ
A20	Eq-Temporal-Unit-Value T92 hour
A21	Eq-Temporal-Period-Value T93 past
A22	Eq-Temporal-Period-Value T96 past
A23	Severity-Value T98 severe
A24	Eq-Operator-Value T101 GTEQ
A25	Eq-Operator-Value T103 LTEQ
A26	Eq-Temporal-Unit-Value T105 year
A27	Eq-Operator-Value T109 LTEQ
A28	Eq-Temporal-Unit-Value T111 month
A29	Severity-Value T113 severe
A30	Severity-Value T116 severe
A31	Eq-Temporal-Period-Value T121 past
A33	Eq-Operator-Value T124 LTEQ
A34	Eq-Temporal-Unit-Value T126 month
A35	Eq-Temporal-Period-Value T129 past
A36	Eq-Temporal-Unit-Value T130 month
A12	Eq-Operator-Value T74 GTEQ
A37	Observation-Type-Value E48 clinical-score
A38	Assertion-Type-Value E71 hypothetical
A39	Eq-Temporal-Recency-Value T141 most-recent-time
A41	Observation-Type-Value E17 clinical-score
A42	Observation-Type-Value E18 clinical-score
A43	Observation-Type-Value E31 clinical-score
A44	Acuteness-Type-Value T122 acute
R1	Equivalent-To Arg1:E69 Arg2:E15
R2	Found-By Arg1:E13 Arg2:E15
R3	Abbrev-Of Arg1:E18 Arg2:E17
R4	Equivalent-To Arg1:E31 Arg2:E30
R5	Treatment-For Arg1:E45 Arg2:E43
R6	Equivalent-To Arg1:E48 Arg2:E47
R7	Or Arg1:E4 Arg2:E6
R8	Or Arg1:E7 Arg2:E68
R9	Or Arg1:E18 Arg2:E21
R10	Before Arg1:E70 Arg2:E25
R11	Or Arg1:E25 Arg2:E27
R12	Or Arg1:E30 Arg2:E34
R13	Or Arg1:E37 Arg2:E39
R14	Before Arg1:E40 Arg2:E42
R15	Or Arg1:E43 Arg2:E47
R16	Before Arg1:E52 Arg2:E54
R17	During Arg1:E59 Arg2:E61
R18	Or Arg1:E61 Arg2:E63
R19	Before Arg1:E63 Arg2:E65
R20	Or Arg1:E56 Arg2:E71
R21	During Arg1:E66 Arg2:E74
R22	Or Arg1:E36 Arg2:E37
